We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCW
9951
DELISTED
Mister Car Wash
MCW
$269K ﹤0.01%
24,653
-9,815
-28% -$128K
MYY icon
9952
ProShares Short MidCap400
MYY
$2.86M
$269K ﹤0.01%
9,906
-12,291
-55% -$311K
PSQ icon
9953
ProShares Short QQQ
PSQ
$636M
$269K ﹤0.01%
+3,738
New +$249K
VCEL icon
9954
PUT
Vericel Corp
VCEL
$2.26B
$269K ﹤0.01%
10,700
-4,900
-31% -$145K
VUZI icon
9955
Vuzix
VUZI
$262M
$269K ﹤0.01%
37,906
-20,989
-36% -$123K
YALA
9956
Yalla Group
YALA
$832M
$269K ﹤0.01%
+69,052
New +$272K
MMX
9957
PUT
DELISTED
Maverix Metals Inc. Common Shares
MMX
$269K ﹤0.01%
61,800
-14,900
-19% -$67.8K
FLXS icon
9958
Flexsteel Industries
FLXS
$301M
$268K ﹤0.01%
+14,886
New +$298K
HRTX icon
9959
Heron Therapeutics
HRTX
$63.9M
$268K ﹤0.01%
95,984
-115,588
-55% -$464K
IBRX icon
9960
PUT
ImmunityBio
IBRX
$8.02B
$268K ﹤0.01%
72,100
-21,200
-23% -$85.2K
IOSP icon
9961
CALL
Innospec
IOSP
$2.31B
$268K ﹤0.01%
+2,800
New +$272K
KEX icon
9962
PUT
Kirby Corp
KEX
$7.32B
$268K ﹤0.01%
+4,400
New +$286K
SBH icon
9963
CALL
Sally Beauty Holdings
SBH
$1.54B
$268K ﹤0.01%
22,500
-5,900
-21% -$85.7K
GXDW
9964
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$6.46M
$268K ﹤0.01%
9,270
-2,857
-24% -$90.7K
OLK
9965
PUT
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$268K ﹤0.01%
+17,600
New +$228K
CANO.WS
9966
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$268K ﹤0.01%
394,509
+9
+0% +$9
CORZ
9967
PUT
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$268K ﹤0.01%
179,900
-18,200
-9% -$83.6K
BURU
9968
CALL
DELISTED
NUBURU INC
BURU
$267K ﹤0.01%
134
+80
+148% +$158K
GGAL icon
9969
PUT
Galicia Financial Group
GGAL
$6.97B
$267K ﹤0.01%
38,700
-15,900
-29% -$142K
KRO icon
9970
CALL
KRONOS Worldwide
KRO
$975M
$267K ﹤0.01%
14,500
-1,300
-8% -$22.2K
KZIA
9971
CALL
Kazia Therapeutics
KZIA
$154M
$267K ﹤0.01%
+1,274
New +$391K
MSB
9972
CALL
Mesabi Trust
MSB
$301M
$267K ﹤0.01%
10,900
-11,700
-52% -$304K
MTA
9973
Metalla Royalty & Streaming
MTA
$912M
$267K ﹤0.01%
55,267
-70,422
-56% -$410K
NTGR icon
9974
PUT
NETGEAR
NTGR
$656M
$267K ﹤0.01%
14,400
-6,400
-31% -$131K
PRG icon
9975
CALL
PROG Holdings
PRG
$1.7B
$267K ﹤0.01%
16,200
-16,200
-50% -$415K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.